| Identification | Back Directory | [Name]
8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-6-vinylpyrido[2,3-d]pyrimidin-7(8H)-one | [CAS]
2204863-06-7 | [Synonyms]
Palbociclib-3
Palbociclib-021
Pyrido[2,3-d]pyrimidin-7(8H)-one, 8-cyclopentyl-6-ethenyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-
Palbociclib impurity 22/8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl) amino)-6-vinylpyrido[2,3-d]pyrimidin-7(8H)-one | [Molecular Formula]
C24H29N7O | [MDL Number]
MFCD28359443 | [MOL File]
2204863-06-7.mol | [Molecular Weight]
431.53 |
| Chemical Properties | Back Directory | [Boiling point ]
672.3±65.0 °C(Predicted) | [density ]
1.306±0.06 g/cm3(Predicted) | [solubility ]
DMSO (Very Slightly, Heated) | [form ]
Solid | [pka]
8.66±0.10(Predicted) | [color ]
Light Yellow | [InChIKey]
BAMRZESJXFABIT-UHFFFAOYSA-N | [SMILES]
C1(NC2=NC=C(N3CCNCC3)C=C2)=NC=C2C(C)=C(C=C)C(=O)N(C3CCCC3)C2=N1 |
| Hazard Information | Back Directory | [Uses]
Desoxo-palbociclib is a derivative compound of Palbociclib (P139900). Palbociclib (also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
|
|